BOSTON – Sync Project Inc. has raised $5 million in financing to develop a physiologically-responsive music health digital platform to treat conditions like sleep apnea and pain.
“Developing music as precision medicine requires the right mix of people and funding that bridge consumer technology, music and biotech,” said Marko Ahtisaari, CEO and co-founder of Sync Project.
The company is building a unique set of data on the impact of musical properties like beat, key and timbre on an individual’s heart rate, brain activity and sleep patterns. Datasets generated through the Sync Project’s consumer initiatives will be further validated through controlled clinical trails in individuals suffering from sleep disorders, pain and other disorders.
Sync Project aims to commercialize the clinical applications of this platform and deliver a personalized, low-cost, non-invasive therapy across a range of conditions.